The Medicines Company - Company & Market Research Reports

The Medicines Company aims to be a leader in the areas of serious infectious disease care, acute cardiovascular care, and surgery and perioperative care. Its marketed products include Angiomax, an anticoagulant used during coronary angioplasties; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
Pneumonia Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pneumonia Drug Development Pipeline Review, 2017

  • Report
  • 123 Pages
From
Minocin 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Minocin 2017 U.S. Promotional Audit Report

  • Report
  • 32 Pages
From
Antibiotics: The Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts - Product Thumbnail Image

Antibiotics: The Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts

  • Report
  • 299 Pages
From
Hyperlipidemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Hyperlipidemia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 173 Pages
From
Global Antibiotics Market 2017-2021 - Product Thumbnail Image

Global Antibiotics Market 2017-2021

  • Report
  • 118 Pages
From
Antibiotics, Medicinal Plants, Superbugs And The Coming Antimicrobial Resistant Drugs Pandemic: Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts - Product Thumbnail Image

Antibiotics, Medicinal Plants, Superbugs And The Coming Antimicrobial Resistant Drugs Pandemic: Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts

  • Report
  • 373 Pages
From
2018 Ischaemic Heart Disorders Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Ischaemic Heart Disorders Market - Product Thumbnail Image

2018 Ischaemic Heart Disorders Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Ischaemic Heart Disorders Market

  • Report
  • 70 Pages
From
2018 Atherosclerotic Heart Disease Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Atherosclerotic Heart Disease Market - Product Thumbnail Image

2018 Atherosclerotic Heart Disease Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Atherosclerotic Heart Disease Market

  • Report
  • 70 Pages
From
2018 Coronary Artery Disease Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Coronary Artery Disease Market - Product Thumbnail Image

2018 Coronary Artery Disease Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Coronary Artery Disease Market

  • Report
  • 70 Pages
From
Blood Pressure Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Blood Pressure Disorders Drug Development Pipeline Review, 2018

  • Report
  • 213 Pages
From
Bacterial Pneumonia - Pipeline Insight, 2018 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026 - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA): Competitive Landscape to 2026

  • Report
  • 49 Pages
From
Bacterial Sepsis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Bacterial Sepsis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 52 Pages
From
Heart Valve Disease Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Heart Valve Disease Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 136 Pages
From
Percutaneous Coronary Intervention Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Percutaneous Coronary Intervention Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 182 Pages
From
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 1479 Pages
From
Aortic Valve Stenosis Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Aortic Valve Stenosis Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 68 Pages
From
Aortic Aneurysm Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Aortic Aneurysm Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 81 Pages
From
Loading Indicator
adroll